Overcoming the dependence on animal models for osteoarthritis therapeutics–the promises and prospects of in vitro models
Osteoarthritis (OA) is a musculoskeletal disease characterized by progressive degeneration
of osteochondral tissues. Current treatment is restricted to the reduction of pain and loss of …
of osteochondral tissues. Current treatment is restricted to the reduction of pain and loss of …
[HTML][HTML] Cartilage and bone destruction in arthritis: pathogenesis and treatment strategy: a literature review
D Tateiwa, H Yoshikawa, T Kaito - Cells, 2019 - mdpi.com
Arthritis is inflammation of the joints accompanied by osteochondral destruction. It can take
many forms, including osteoarthritis, rheumatoid arthritis, and psoriatic arthritis. These …
many forms, including osteoarthritis, rheumatoid arthritis, and psoriatic arthritis. These …
[HTML][HTML] Osteoarthritis: a narrative review of molecular approaches to disease management
Osteoarthritis (OA) is a chronic, progressive degenerative whole joint disease that affects the
articular cartilage, subchondral bone, ligaments, capsule, and synovium. While it is still …
articular cartilage, subchondral bone, ligaments, capsule, and synovium. While it is still …
Inflammation and joint tissue interactions in OA: implications for potential therapeutic approaches
It is increasingly recognized that the pathogenesis of cartilage degradation in osteoarthritis
(OA) is multifactorial and involves the interactions between cartilage and its surrounding …
(OA) is multifactorial and involves the interactions between cartilage and its surrounding …
[HTML][HTML] Recent advances in understanding the phenotypes of osteoarthritis
Recent research in the field of osteoarthritis (OA) has focused on understanding the
underlying molecular and clinical phenotypes of the disease. This narrative review article …
underlying molecular and clinical phenotypes of the disease. This narrative review article …
[HTML][HTML] OA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed?
MPH Le Graverand-Gastineau - Osteoarthritis and cartilage, 2009 - Elsevier
OBJECTIVE: The purpose of this article is to review the current status of drug development
as it relates to both molecular targets and clinical trials for osteoarthritis (OA). METHODS: A …
as it relates to both molecular targets and clinical trials for osteoarthritis (OA). METHODS: A …
Osteoarthritis in 2007.
S Krasnokutsky, J Samuels… - Bulletin of the NYU …, 2007 - search.ebscohost.com
Osteoarthritis (OA) is often a progressive and disabling disease resulting from a combination
of risk factors, including age, genetics, trauma, and knee alignment, as well as an imbalance …
of risk factors, including age, genetics, trauma, and knee alignment, as well as an imbalance …
Stem cell-based microphysiological osteochondral system to model tissue response to interleukin-1β
Osteoarthritis (OA) is a chronic degenerative disease of the articular joint that involves both
bone and cartilage degenerative changes. An engineered osteochondral tissue within …
bone and cartilage degenerative changes. An engineered osteochondral tissue within …
Pathophysiological landscape of osteoarthritis
P Kulkarni, A Martson, R Vidya, S Chitnavis… - Advances in clinical …, 2021 - Elsevier
A sharp rise in osteoarthritis (OA) incidence is expected as over 25% of world population
ages in the coming decade. Although OA is considered a degenerative disease, mounting …
ages in the coming decade. Although OA is considered a degenerative disease, mounting …
[HTML][HTML] The hallmarks of osteoarthritis and the potential to develop personalised disease-modifying pharmacological therapeutics
Osteoarthritis (OA) is an age-related condition and the leading cause of pain, disability and
shortening of adult working life in the UK. The incidence of OA increases with age, with 25 …
shortening of adult working life in the UK. The incidence of OA increases with age, with 25 …